# PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

> **NCT01415167** · — · COMPLETED · sponsor: **Prometheus Laboratories** · enrollment: 1690 (actual)

## Conditions studied

- Metastatic Renal Cell Carcinoma
- Metastatic Melanoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01415167
- **Lead sponsor:** Prometheus Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2018-04
- **Final completion:** 2018-05
- **Target enrollment:** 1690 (ACTUAL)
- **Last updated:** 2019-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01415167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01415167, "PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01415167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*